B. Riley raised the firm’s price target on Zymeworks (ZYME) to $40 from $30 and keeps a Buy rating on the shares. Zymeworks’ shift to a royalty-aggregation strategy aims to optimize future de-risked ...

Get the latest analysis on Cognition Therapeutics (CGTX): risks, funding outlook, and zervimesine’s potential in Alzheimer’s ...

The USS Gerald R. Ford's arrival in the Caribbean sets a “shot clock” for the U.S. to either strike Venezuela or stand down.

The Cyprus Securities and Exchange Commission (CySEC) said the listed websites — including fernrise.com, market-trading.ltd, ...

IBM Is an AI and IT Leader Set for Growth, Says Analyst. Plus, Lowe’s, Rocket, and More Stocks.

Corporate representation at COP30 has sharply declined since the 2021 Glasgow summit, replacing high-profile marketing stunts ...

A loud boom has been heard throughout Jefferson County over the last couple of months. Those who have heard it say it usually ...

The China-aligned advanced persistent threat (APT) tracked as 'PlushDaemon' is hijacking software update traffic to deliver ...

Quantum computers, which operate leveraging effects rooted in quantum mechanics, have the potential of tackling some ...

The global geothermal power market is projected to reach $14.5 billion by 2034, driven by its high-capacity baseload power, ...

At a time when every movie seemingly falls into a binary of either masterpiece or trainwreck, I instead favor these six ...

APT24 and Autumn Dragon launch multi-year espionage campaigns using BADAUDIO, supply chain attacks, and new CVE-2025-8088 ...